TVTX Travere Therapeutics, Inc. - Common Stock
$64.91
价格 · 八月 19, 2026
截至...的财报数据 八月 4, 2026
52周区间
$17–$66
97% of range
分析师评级
BUY
21 analysts
目标价
$73
+12% upside
P/E (TTM)
-223.8
ROE
-34.6%
净利润率
-5.2%
TVTX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$64.91
市值
$5.90B
P/E (TTM)
-223.8
每股收益 (TTM)
$-0.29
营收 (TTM)
$491M
股息收益率
—
ROE
-34.6%
负债/权益
—
52周区间
$17 – $66
TVTX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$491M
2016-12-31
→
2025-12-31
EPS
$-0.29
2016-12-31
→
2025-12-31
自由现金流
—
2016-12-31
→
2023-12-31
利润率
-5.2%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
指标
5年趋势
TVTX
同行中位数
P/E (TTM)
-223.8
37.2
P/S (TTM) (市销率 (TTM))
12.0
9.9
P/B (市净率)
51.4
8.3
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
TVTX
同行中位数
Operating Margin (营业利润率)
-12.8%
—
Net Profit Margin (净利润率)
-5.2%
-15.1%
ROA
-4.3%
-23.3%
ROE
-34.6%
-30.6%
ROIC
-55.8%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
TVTX
同行中位数
Current Ratio (流动比率)
2.7
6.3
Quick Ratio (速动比率)
1.1
—
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
TVTX
同行中位数
Revenue YoY (营收同比增长)
110.5%
—
Revenue CAGR 3Y (营收3年复合年增长率)
64.9%
—
Revenue CAGR 5Y (营收5年复合年增长率)
19.9%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
TVTX
同行中位数
TVTX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
21 位分析师
- 强烈买入 8 38.1%
- 买入 11 52.4%
- 持有 2 9.5%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
14 位分析师 · 2026-08-14
中位数
$75.00
现在
$64.91
最低
$49.00
最高
$90.00
中位数目标
$75.00
+15.5%
平均目标
$72.79
+12.1%
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
平均惊喜
0.16%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.06 | $-0.14 | 0.20% |
| 2026年3月31日 | $-0.40 | $-0.27 | -0.13% |
| 2025年12月31日 | $0.03 | $-0.12 | 0.15% |
| 2025年9月30日 | $0.28 | $-0.21 | 0.49% |
| 2025年6月30日 | $-0.14 | $-0.30 | 0.16% |
| 2025年3月31日 | $-0.47 | $-0.55 | 0.08% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| PBLS | — | — | — | — | — | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $491M | $233M | $145M | $109M | $132M | $198M | $175M | $164M | $155M | $134M | $100M | $28M | |
| Cost of Revenue | $10M | $8M | $11M | $4M | $4M | $6M | $5M | $6M | $4M | $5M | $2M | $571.0K | |
| R&D Expense | · | · | · | $8M | · | · | $141M | $124M | $78M | $71M | $50M | $48M | |
| SG&A Expense | $337M | $264M | $266M | $198M | $126M | $136M | $129M | $104M | $101M | $92M | $80M | $60M | |
| Operating Expenses | $554M | $557M | $533M | $429M | $331M | $374M | $313M | $244M | $209M | $192M | $151M | $108M | |
| Operating Income | $-63M | $-324M | $-388M | $-320M | $-199M | $-176M | $-137M | $-80M | $-54M | $-58M | $-51M | $-80M | |
| Interest Expense | · | · | $11M | $11M | $20M | $19M | $19M | $10M | $4M | $5M | $8M | $7M | |
| Interest Income | $13M | $18M | $22M | $6M | $2M | $5M | $10M | $5M | $3M | · | · | · | |
| Other Non-op | $12M | $-3M | $2M | $974.0K | $231.0K | $1M | $-314.0K | $-474.0K | $1M | $-264.0K | $-296.0K | $2M | |
| Pretax Income | $-49M | $-321M | $-376M | $-331M | $-217M | $-189M | $-146M | $-102M | $-58M | $-58M | $105M | $-113M | |
| Income Tax | $988.0K | $120.0K | $223.0K | $313.0K | $409.0K | $-19M | $-21.0K | $811.0K | $1M | $-10M | $-12M | $-2M | |
| Net Income | $-26M | $-322M | $-111M | $-278M | $-180M | $-169M | $-146M | $-103M | $-60M | $-48M | $117M | $-111M | |
| EPS (Basic) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 | $3.49 | $-4.43 | |
| EPS (Diluted) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 | $3.17 | $-4.43 | |
| Shares (Basic) | 89,211,813 | 78,888,861 | 74,267,418 | 63,758,515 | 59,832,287 | 47,539,631 | 42,339,961 | 40,433,171 | 38,769,816 | 36,997,865 | 33,560,249 | 25,057,509 | |
| Shares (Diluted) | 89,211,813 | 78,888,861 | 74,267,418 | 63,758,515 | 59,832,287 | 47,539,631 | 42,339,961 | 40,433,171 | 38,769,816 | 38,288,012 | 37,581,439 | 25,057,509 | |
| EBITDA | $-2M | $-280M | $-350M | $-233M | $-135M | $-152M | $-117M | $-61M | $-36M | $-42M | · | · |
资产负债表 29
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $59M | $58M | $62M | $166M | $85M | $62M | $103M | $99M | $41M | $38M | $18M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $201M | $215M | $192M | $10M | |
| Receivables | $80M | $27M | $21M | $17M | $16M | $16M | $18M | $13M | $14M | $19M | $12M | $8M | |
| Inventory | $36M | $42M | $9M | $5M | $7M | $8M | $6M | $6M | $5M | $3M | $3M | $801.0K | |
| Prepaid Expense | $29M | $13M | $19M | $12M | $7M | $8M | $5M | $4M | $3M | $5M | $2M | $813.0K | |
| Current Assets | $438M | $417M | $617M | $486M | $583M | $410M | $429M | $496M | $326M | $332M | $302M | $37M | |
| PP&E (Net) | $4M | $5M | $7M | $9M | $11M | $9M | $3M | $3M | $3M | $3M | $428.0K | $671.0K | |
| PP&E (Gross) | $14M | $14M | $15M | $14M | $14M | $13M | $5M | $4M | $4M | $3M | · | · | |
| Accum. Depreciation | $10M | $9M | $7M | $5M | $3M | $4M | $2M | $1M | $585.0K | $200.0K | · | · | |
| Goodwill | · | $800.0K | $800.0K | $800.0K | $900.0K | $900.0K | $936.0K | $936.0K | $936.0K | $936.0K | $936.0K | $936.0K | |
| Intangibles | $114M | $104M | $104M | $97M | $148M | $154M | $157M | $187M | $185M | $182M | $162M | $94M | |
| Other Non-current Assets | $9M | $18M | $11M | $11M | $11M | $8M | $15M | $8M | $6M | $7M | $2M | $2M | |
| Total Assets | $605M | $594M | $789M | $673M | $777M | $607M | $605M | $709M | $520M | $525M | $512M | $135M | |
| Accounts Payable | $25M | $24M | $42M | $17M | $15M | $12M | $27M | $7M | $19M | $8M | $8M | $7M | |
| Accrued Liabilities | $126M | $86M | $119M | $96M | $75M | $57M | $52M | $50M | $36M | $33M | $24M | $28M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | $40M | |
| Current Liabilities | $160M | $201M | $178M | $142M | $124M | $93M | $95M | $105M | $86M | $83M | $87M | $108M | |
| Capital Leases | $11M | $17M | $23M | $28M | $31M | $28M | $7M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $6M | $24M | $141.0K | |
| Other Non-current Liabilities | $8M | $7M | $10M | $9M | $12M | $12M | $21M | $18M | $2M | $4M | $3M | $2M | |
| Total Liabilities | $490M | $535M | $588M | $630M | $475M | $396M | $384M | $391M | $227M | $218M | $212M | $173M | |
| Common Stock | $9.0K | $9.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | $1.59B | $1.51B | $1.33B | $1.06B | $1.07B | $798M | $637M | $590M | $472M | $421M | $366M | $141M | |
| Retained Earnings | $-1.47B | $-1.45B | $-1.13B | $-1.01B | $-766M | $-586M | $-416M | $-270M | $-178M | $-113M | $-65M | $-179M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $0 | $3M | |
| AOCI | $-1M | $-80.0K | $-1M | $-3M | $-562.0K | $-902.0K | $726.0K | $-2M | $-1M | $-490.0K | $-682.0K | $4M | |
| Stockholders' Equity | $115M | $59M | $201M | $43M | $302M | $211M | $221M | $318M | $293M | $308M | $300M | $-37M | |
| Liabilities + Equity | $605M | $594M | $789M | $673M | $777M | $607M | $605M | $709M | $520M | $525M | $512M | $135M | |
| Shares Outstanding | 90,922,868 | 87,452,835 | 75,367,117 | 64,290,570 | 62,491,498 | 52,248,431 | 43,088,921 | 41,389,524 | 39,373,745 | 37,906,669 | 36,465,853 | 26,048,480 |
现金流 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $61M | $44M | $39M | $21M | $13M | $25M | $20M | $19M | $18M | $16M | $13M | $5M | |
| Stock-based Comp | $45M | $37M | $44M | $38M | $30M | $24M | $21M | $20M | $27M | $29M | $26M | $16M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-6M | $-23M | $-16M | $-2M | |
| Amort. of Intangibles | $59M | $42M | $36M | $19M | $11M | $22M | $20M | $18M | $17M | $16M | $13M | $5M | |
| Restructuring | $0 | $2M | $11M | $0 | $0 | $0 | $0 | $-242.0K | $4M | $893.0K | $0 | · | |
| Other Non-cash | $-42M | $4M | $-251M | $20M | $108M | $78M | $47M | $39M | $29M | $24M | · | · | |
| Operating Cash Flow | $38M | $-237M | $-280M | $-186M | $-15M | $-43M | $-58M | $-25M | $7M | $-3M | $-1M | $-46M | |
| CapEx | · | · | $668.0K | $191.0K | $5M | $7M | $195.0K | $727.0K | $887.0K | $1M | $22.0K | $663.0K | |
| Investing Cash Flow | $28M | $99M | $56M | $-33M | $-138M | $-61M | $20M | $-203M | $46M | $10M | $-81M | · | |
| Net Debt Issued | · | · | · | · | · | $0 | $0 | $-40M | · | · | · | · | |
| Stock Issued | $0 | $135M | $191M | $0 | $189M | · | · | · | $0 | $0 | $149M | $40M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $0 | $0 | $2M | |
| Net Stock Activity | $0 | $135M | $191M | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $-33M | $139M | $219M | $118M | $232M | $128M | $-2M | $232M | $5M | $-4M | $102M | $95M | |
| Net Change in Cash | $34M | $359.0K | $-4M | $-104M | $81M | $22M | $-40M | $3M | $58M | $3M | $20M | $12M | |
| Taxes Paid | · | $453.0K | $578.0K | $996.0K | $-16M | $-3M | $656.0K | $218.0K | · | · | · | · | |
| Free Cash Flow | · | · | $-281M | $-186M | $-20M | $-50M | $-58M | $-26M | $7M | $-3M | · | · | |
| Levered FCF | · | · | $-292M | $-198M | $-40M | $-67M | $-77M | $-36M | $5M | $-4M | · | · |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.8% | -138.9% | -267.2% | -125.7% | -71.1% | -88.8% | -78.3% | -48.7% | -34.7% | -43.6% | · | · | |
| Net Margin | -5.2% | -137.9% | -76.7% | -131.3% | -79.2% | -85.4% | -83.5% | -62.5% | -38.6% | -35.9% | · | · | |
| Pretax Margin | -10.0% | -137.5% | -259.0% | -131.2% | -79.0% | -95.2% | -83.5% | -62.0% | -37.7% | -43.1% | · | · | |
| EBITDA Margin | -0.42% | -120.2% | -240.7% | -110.1% | -59.4% | -76.4% | -66.7% | -37.4% | -23.2% | -31.5% | · | · | |
| ROA | -4.3% | -46.5% | -15.2% | -38.4% | -26.0% | -28.0% | -22.3% | -16.7% | · | -9.2% | · | · | |
| ROE | -34.6% | -2246.8% | -46.4% | -388.1% | -59.1% | -66.1% | -62.7% | -32.2% | · | -15.8% | · | · | |
| ROIC | -55.8% | -548.4% | -193.4% | -622.8% | -53.7% | -74.9% | -62.1% | -25.4% | · | -15.7% | · | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.1 | 3.5 | 3.4 | 4.7 | 4.4 | 4.5 | 4.7 | · | 4.0 | · | · | |
| Quick Ratio | 1.1 | 0.4 | 0.4 | 0.6 | 1.5 | 1.1 | 0.8 | 1.1 | · | 3.3 | · | · | |
| Interest Coverage | · | · | -34.3 | -23.6 | -8.0 | -9.2 | -7.3 | -8.2 | -44.8 | -72.8 | · | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | |
| Inventory Turnover | 0.3 | 1.0 | 1.6 | 1.1 | 0.9 | 0.9 | 0.9 | 1.0 | · | 1.7 | · | · | |
| Receivables Turnover | 9.2 | 9.7 | 7.7 | 13.0 | 14.3 | 11.7 | 11.4 | 11.6 | · | 8.6 | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 110.5% | 60.6% | 32.7% | -17.0% | -33.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 64.9% | 20.9% | -9.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.9% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $491M | $233M | $145M | $109M | $132M | $198M | $175M | $164M | $155M | $134M | $100M | $28M | |
| Net Income TTM | $-26M | $-322M | $-111M | $-278M | $-180M | $-169M | $-146M | $-103M | $-60M | $-48M | $117M | $-111M | |
| Market Cap | $3.47B | $1.52B | $678M | $1.35B | $1.94B | $1.42B | $612M | $937M | · | $718M | · | · | |
| P/E | -131.8 | -4.3 | -6.0 | -4.8 | -10.3 | -7.7 | -4.1 | -8.9 | -13.7 | -14.7 | 6.1 | -2.8 | |
| P/S | 7.1 | 6.5 | 4.7 | 12.4 | 14.7 | 7.2 | 3.5 | 5.7 | · | 5.4 | · | · | |
| P/B | 30.3 | 25.8 | 3.4 | 31.6 | 6.4 | 6.7 | 2.8 | 2.9 | · | 2.3 | · | · | |
| P / Tangible Book | 3618.9 | · | 7.1 | · | 12.7 | 25.3 | · | · | · | · | · | · | |
| P / Cash Flow | 91.9 | -6.4 | -2.4 | -7.3 | -131.1 | -33.3 | -10.5 | -37.5 | · | -449.6 | · | · | |
| P / FCF | · | · | -2.4 | -7.3 | -97.5 | -28.8 | -10.5 | -36.5 | · | -237.3 | · | · | |
| Earnings Yield | -0.76% | -23.4% | -16.7% | -20.8% | -9.7% | -13.1% | -24.4% | -11.2% | -7.3% | -6.8% | 16.4% | -36.2% |
损益表 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $127M | $130M | $165M | $114M | $82M | $75M | $63M | $54M | $41M | $45M | $37M | $32M | $31M | $-21M | $28M | |
| Cost of Revenue | $2M | $2M | $3M | $2M | $2M | $5M | $3M | $2M | $2M | $2M | $5M | $1M | $1M | $4M | $-883.0K | $1M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $8M | · | · | |
| SG&A Expense | $96M | $80M | $102M | $86M | $63M | $60M | $70M | $66M | $65M | $64M | $64M | $68M | $68M | $66M | $45M | $52M | |
| Operating Expenses | $166M | $164M | $162M | $140M | $127M | $124M | $136M | $119M | $122M | $181M | $139M | $130M | $136M | $128M | $84M | $111M | |
| Operating Income | $4M | $-37M | $-32M | $25M | $-13M | $-43M | $-61M | $-56M | $-68M | $-139M | $-94M | $-93M | $-104M | $-97M | $-106M | $-83M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | |
| Other Non-op | $-169.0K | $-91.0K | $11M | $487.0K | $-526.0K | $549.0K | $-581.0K | $520.0K | $-3M | $238.0K | $1M | $335.0K | $-201.0K | $87.0K | $872.0K | $-586.0K | |
| Pretax Income | $-35M | $-37M | $-21M | $26M | $-13M | $-41M | $-60M | $-55M | $-70M | $-136M | $-89M | $-89M | $-102M | $-96M | $-104M | $-84M | |
| Income Tax | $-204.0K | $-120.0K | $921.0K | $8.0K | $20.0K | $39.0K | $-72.0K | $-84.0K | $85.0K | $191.0K | $68.0K | $12.0K | $65.0K | $78.0K | $63.0K | $145.0K | |
| Net Income | $-35M | $-37M | $3M | $26M | $-13M | $-41M | $-60M | $-55M | $-70M | $-136M | $-90M | $151M | $-86M | $-86M | $-66M | $-70M | |
| EPS (Basic) | $-0.37 | $-0.40 | $0.03 | $0.29 | $-0.14 | $-0.47 | $-0.71 | $-0.70 | $-0.91 | $-1.76 | $-1.07 | $1.97 | $-1.13 | $-1.27 | $-1.03 | $-1.09 | |
| EPS (Diluted) | $-0.37 | $-0.40 | $0.04 | $0.28 | $-0.14 | $-0.47 | $-0.71 | $-0.70 | $-0.91 | $-1.76 | $-1.07 | $1.97 | $-1.13 | $-1.27 | $-1.03 | $-1.09 | |
| Shares (Basic) | 93,479,416 | 91,868,862 | -177,320,204 | 89,230,420 | 88,945,624 | 88,355,973 | -153,527,256 | 77,779,379 | 77,500,245 | 77,136,493 | -146,214,085 | 76,305,603 | 76,001,801 | 68,174,099 | -127,046,470 | 64,033,759 | |
| Shares (Diluted) | 93,479,416 | 91,868,862 | -190,708,344 | 102,618,560 | 88,945,624 | 88,355,973 | -153,527,256 | 77,779,379 | 77,500,245 | 77,136,493 | -146,214,085 | 76,305,603 | 76,001,801 | 68,174,099 | -127,046,470 | 64,033,759 | |
| EBITDA | $4M | $-12M | · | $25M | $-13M | $-30M | · | $-56M | $-68M | $-129M | · | $-93M | $-88M | $-78M | · | $-68M |
资产负债表 25
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $118M | $78M | $93M | $111M | $75M | $62M | $59M | $36M | $32M | $43M | · | $144M | $71M | $161M | · | $151M | |
| Receivables | $81M | $87M | $80M | $83M | $39M | $34M | $27M | $25M | $24M | $23M | · | $15M | $20M | $22M | · | $13M | |
| Inventory | $40M | $37M | $36M | $38M | $38M | $38M | $42M | $43M | $43M | $42M | · | $21M | $19M | $7M | · | $7M | |
| Prepaid Expense | $37M | $34M | $29M | $28M | $17M | $14M | $13M | $16M | $13M | $13M | · | $16M | $12M | $15M | · | $9M | |
| Current Assets | $615M | $393M | $438M | $371M | $380M | $374M | $417M | $325M | $369M | $481M | · | $686M | $542M | $605M | · | $535M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $7M | · | $8M | $9M | $9M | · | $10M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | $800.0K | $800.0K | $800.0K | · | $800.0K | $800.0K | $800.0K | · | $800.0K | $900.0K | $900.0K | · | $900.0K | |
| Intangibles | $132M | $110M | $114M | $109M | $106M | $104M | $104M | $104M | $105M | $101M | · | $107M | $154M | $163M | · | $149M | |
| Other Non-current Assets | $9M | $8M | $9M | $10M | $20M | $19M | $18M | $17M | $17M | $19M | · | $13M | $12M | $11M | · | $11M | |
| Total Assets | $799M | $555M | $605M | $539M | $555M | $549M | $594M | $504M | $551M | $664M | · | $833M | $736M | $808M | · | $726M | |
| Accounts Payable | $7M | $13M | $25M | $18M | $19M | $15M | $24M | $23M | $26M | $17M | · | $25M | $20M | $17M | · | $14M | |
| Accrued Liabilities | $136M | $104M | $126M | $106M | $82M | $77M | $86M | $84M | $80M | $140M | · | $96M | $89M | $86M | · | $88M | |
| Current Liabilities | $152M | $125M | $160M | $135M | $190M | $182M | $201M | $190M | $121M | $173M | · | $139M | $136M | $131M | · | $131M | |
| Capital Leases | $8M | $10M | $11M | $13M | $14M | $16M | $17M | $19M | $20M | $21M | · | $24M | $25M | $26M | · | $28M | |
| Other Non-current Liabilities | $12M | $9M | $8M | $6M | $8M | $7M | $7M | $16M | $17M | $16M | · | $8M | $9M | $9M | · | $9M | |
| Total Liabilities | $775M | $456M | $490M | $465M | $523M | $516M | $535M | $535M | $536M | $589M | · | $553M | $620M | $619M | · | $626M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | · | $7.0K | $7.0K | $7.0K | · | $6.0K | |
| Paid-in Capital | $1.57B | $1.61B | $1.59B | $1.55B | $1.53B | $1.52B | $1.51B | $1.36B | $1.35B | $1.34B | · | $1.32B | $1.31B | $1.29B | · | $1.05B | |
| Retained Earnings | $-1.54B | $-1.51B | $-1.47B | $-1.48B | $-1.50B | $-1.49B | $-1.45B | $-1.39B | $-1.33B | $-1.26B | · | $-1.04B | $-1.19B | $-1.10B | · | $-948M | |
| AOCI | $-1M | $-1M | $-1M | $-1M | $-812.0K | $-843.0K | $-80.0K | $-1M | $-2M | $-2M | · | $-4M | $-4M | $-2M | · | $303.0K | |
| Stockholders' Equity | $25M | $99M | $115M | $74M | $33M | $33M | $59M | $-30M | $15M | $74M | $201M | $280M | $116M | $189M | $43M | $101M | |
| Liabilities + Equity | $799M | $555M | $605M | $539M | $555M | $549M | $594M | $504M | $551M | $664M | · | $833M | $736M | $808M | · | $726M | |
| Shares Outstanding | 94,174,767 | 92,403,744 | 90,922,868 | 89,456,626 | 89,102,347 | 88,787,429 | 87,452,835 | 77,909,042 | 76,456,562 | 76,108,829 | · | 75,111,517 | 74,971,807 | 74,586,806 | · | 64,150,510 |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $25M | $18M | $16M | $14M | $13M | $12M | $11M | $10M | $10M | $9M | $6M | $8M | $7M | $6M | $-793.0K | |
| Stock-based Comp | $22M | $16M | $11M | $11M | $11M | $11M | $9M | $8M | $10M | $10M | $8M | $11M | $11M | $13M | $9M | $8M | |
| Amort. of Intangibles | $4M | $25M | $18M | $15M | $14M | $12M | $12M | $11M | $10M | $9M | $9M | $11M | $10M | $6M | $-603.0K | $5M | |
| Restructuring | · | · | $0 | $0 | $0 | $0 | $1M | $123.0K | $653.0K | $259.0K | $11M | $0 | $0 | $0 | · | · | |
| Other Non-cash | · | $-45M | · | · | · | $-25M | · | · | · | $-3M | · | · | · | $-18M | · | · | |
| Operating Cash Flow | $58M | $-40M | $61M | $14M | $5M | $-42M | $-36M | $-43M | $-40M | $-119M | $-70M | $-59M | $-69M | $-81M | $-55M | $-40M | |
| CapEx | · | · | · | $140.0K | · | · | · | $0 | $82.0K | $0 | · | $10.0K | $3.0K | $630.0K | · | $13.0K | |
| Investing Cash Flow | $-206M | $22M | $-105M | $87M | $5M | $41M | $-80M | $46M | $29M | $105M | $-17M | $133M | $-24M | $-37M | $-37M | $10M | |
| Financing Cash Flow | $188M | $4M | $27M | $-65M | $1M | $4M | $139M | $46.0K | $782.0K | $-525.0K | $124.0K | $-634.0K | $2M | $217M | $551.0K | $2M | |
| Net Change in Cash | $39M | $-15M | $-18M | $36M | $13M | $3M | $22M | $4M | $-11M | $-15M | $-86M | $73M | $-91M | $100M | $-90M | $-28M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-119M | · | · | · | $-82M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-122M | · | · | · | $-85M | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.3% | -29.0% | · | 15.1% | -11.1% | -52.2% | · | -89.3% | -125.1% | -336.5% | · | -249.6% | -146.7% | -152.7% | · | -127.4% | |
| Net Margin | -20.5% | -29.2% | · | 15.6% | -11.1% | -50.4% | · | -87.1% | -130.1% | -328.9% | · | 406.4% | -143.4% | -151.5% | · | -130.2% | |
| Pretax Margin | -20.6% | -28.9% | · | 15.6% | -11.1% | -50.4% | · | -87.2% | -128.6% | -328.1% | · | -240.5% | -143.3% | -151.3% | · | -129.9% | |
| EBITDA Margin | 2.3% | -9.2% | · | 15.1% | -11.1% | -36.5% | · | -89.3% | -125.1% | -312.6% | · | -249.6% | -146.7% | -136.0% | · | -127.4% | |
| ROA | -5.1% | -6.7% | · | 4.9% | -2.3% | -6.8% | · | -8.2% | -10.9% | -18.5% | · | 19.3% | -11.3% | -10.5% | · | -9.3% | |
| ROE | -121.5% | -56.4% | · | 119.3% | -53.3% | -77.1% | · | -44.0% | -107.0% | -103.4% | · | 79.2% | -62.7% | -43.5% | · | -34.1% | |
| ROIC | 16.0% | -37.3% | · | 33.9% | -38.7% | -130.1% | · | 184.1% | -447.5% | -188.2% | · | -33.1% | -75.2% | -46.1% | · | -67.8% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.0 | 3.1 | · | 2.7 | 2.0 | 2.1 | · | 1.7 | 3.0 | 2.8 | · | 4.9 | 4.0 | 4.6 | · | 4.1 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.4 | 0.6 | 0.5 | · | 0.3 | 0.5 | 0.4 | · | 1.1 | 0.7 | 1.4 | · | 1.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -49.7 | · | -33.1 | -30.2 | -30.0 | · | · |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.8 | · | 0.2 | |
| Receivables Turnover | 2.8 | 2.1 | · | 3.0 | 3.6 | 2.9 | · | 3.2 | 2.4 | 1.9 | · | 2.7 | 3.2 | 3.1 | · | 4.1 |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $576M | $488M | · | $424M | $313M | $240M | · | $203M | $178M | $156M | · | $130M | $120M | $117M | · | $148M | |
| Net Income TTM | $-59M | $-65M | · | $-83M | $-179M | $-303M | · | $-351M | $-146M | $-161M | · | $-87M | $-307M | $-289M | · | $-248M | |
| Market Cap | $5.35B | $2.75B | · | $2.14B | $1.32B | $1.59B | · | $1.09B | $628M | $587M | · | $671M | $1.15B | $1.68B | · | $1.58B | |
| P/E | -90.2 | -40.7 | · | -23.2 | -6.7 | -4.7 | · | -3.1 | -4.4 | -3.7 | · | -6.1 | -3.4 | -5.1 | · | -6.3 | |
| P/S | 9.3 | 5.6 | · | 5.0 | 4.2 | 6.6 | · | 5.4 | 3.5 | 3.8 | · | 5.2 | 9.6 | 14.3 | · | 10.7 | |
| P/B | 218.2 | 27.8 | · | 29.1 | 40.3 | 48.5 | · | -35.8 | 41.5 | 7.9 | · | 2.4 | 9.9 | 8.9 | · | 15.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 3.9 | · | 66.2 | · | · | |
| P / Cash Flow | · | -68.0 | · | · | · | -37.7 | · | · | · | -4.9 | · | · | · | -20.7 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -20.5 | · | · | |
| Earnings Yield | -1.1% | -2.5% | · | -4.3% | -15.0% | -21.4% | · | -32.5% | -22.9% | -27.2% | · | -16.3% | -29.4% | -19.7% | · | -16.0% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $491M | $233M | $145M | $109M | $132M |
| 营业利润率 % | -12.8% | -138.9% | -267.2% | -125.7% | -71.1% |
| 净收入 | $-26M | $-322M | $-111M | $-278M | $-180M |
| 稀释后每股收益 (EPS) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 2.7 | 2.1 | 3.5 | 3.4 | 4.7 |
| 速动比率 | 1.1 | 0.4 | 0.4 | 0.6 | 1.5 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | — | $-281M | $-186M | $-20M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 341 家申报者 · $4.3B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 98 (+52 与上一季度对比) | 27 (-28 与上一季度对比) | 108 (+12 与上一季度对比) | 90 (-2 与上一季度对比) | +8.8M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| FMR LLC | $286681837 | 5046327 | 6.65% | 股份 |
| STATE STREET CORP | $241796085 | 4256224 | 5.61% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $233414906 | 4108694 | 5.41% | 股份 |
| BANK OF AMERICA CORP /DE/ | $218865524 | 3852588 | 5.08% | 股份 |
| VANGUARD GROUP INC | $213624812 | 5590809 | 4.96% | 股份 |
| PERCEPTIVE ADVISORS LLC | $213183729 | 3752574 | 4.94% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $159779000 | 2812514 | 3.71% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $145965114 | 2569356 | 3.39% | 股份 |
| Rock Springs Capital Management LP | $123792910 | 2179069 | 2.87% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $115630571 | 2034915 | 2.68% | 股份 |
| Kynam Capital Management, LP | $113620000 | 2000000 | 2.64% | 股份 |
| Stephens Investment Management Group LLC | $106536020 | 1875304 | 2.47% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $104137218 | 1833079 | 2.42% | 股份 |
| EMERALD ADVISERS, LLC | $90946334 | 1600886 | 2.11% | 股份 |
| ARMISTICE CAPITAL, LLC | $89335941 | 1572539 | 2.07% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $88944917 | 1565656 | 2.06% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $87579262 | 1541617 | 2.03% | 股份 |
| Qube Research & Technologies Ltd | $81989896 | 1443230 | 1.90% | 股份 |
| Driehaus Capital Management LLC | $81757203 | 1439134 | 1.90% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $65726898 | 1156960 | 1.52% | 股份 |
| MPM BIOIMPACT LLC | $63782348 | 1122731 | 1.48% | 股份 |
| D. E. Shaw & Co., Inc. | $62429361 | 1098915 | 1.45% | 股份 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $58629283 | 1032024 | 1.36% | 股份 |
| GOLDMAN SACHS GROUP INC | $57488823 | 1011949 | 1.33% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $56379267 | 992418 | 1.31% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $46997663 | 827278 | 1.09% | 股份 |
| Eversept Partners, LP | $45389656 | 798973 | 1.05% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $37598221 | 661824 | 0.87% | 股份 |
| Ensign Peak Advisors, Inc | $33621010 | 591815 | 0.78% | 股份 |
| ARMISTICE CAPITAL, LLC | $28405000 | 500000 | 0.66% | 买入期权 |
| PANAGORA ASSET MANAGEMENT INC | $27878030 | 490724 | 0.65% | 股份 |
| TWO SIGMA ADVISERS, LP | $27721355 | 725500 | 0.64% | 股份 |
| Point72 Asset Management, L.P. | $27204037 | 478860 | 0.63% | 股份 |
| Candriam S.C.A. | $26690051 | 470265 | 0.62% | 股份 |
| Graham Capital Management, L.P. | $25376800 | 446696 | 0.59% | 股份 |
| Assenagon Asset Management S.A. | $24275197 | 427305 | 0.56% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $22086489 | 378842 | 0.51% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21854807 | 384700 | 0.51% | 卖出期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21565076 | 379600 | 0.50% | 买入期权 |
| Integral Health Asset Management, LLC | $21303750 | 375000 | 0.49% | 股份 |
| Pictet Asset Management Holding SA | $20067022 | 344510 | 0.47% | 股份 |
| Artia Global Partners LP | $19260465 | 339033 | 0.45% | 股份 |
| Capricorn Fund Managers Ltd | $18276970 | 321721 | 0.42% | 股份 |
| JANE STREET GROUP, LLC | $17332731 | 305100 | 0.40% | 卖出期权 |
| JANE STREET GROUP, LLC | $17258708 | 303797 | 0.40% | 股份 |
| Impax Asset Management Group plc | $17043000 | 300000 | 0.40% | 股份 |
| Affinity Asset Advisors, LLC | $17043000 | 300000 | 0.40% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $16870127 | 296957 | 0.39% | 股份 |
| Elmind Capital, LP | $16622606 | 292600 | 0.39% | 股份 |
| FIRST TRUST ADVISORS LP | $16274815 | 286478 | 0.38% | 股份 |
| LOOMIS SAYLES & CO L P | $15660870 | 275671 | 0.36% | 股份 |
| Palisades Investment Partners, LLC | $15513675 | 273080 | 0.36% | 股份 |
| Woodline Partners LP | $14432808 | 254054 | 0.33% | 股份 |
| ORBIMED ADVISORS LLC | $14372930 | 253000 | 0.33% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $13896067 | 244606 | 0.32% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $11676500 | 205536 | 0.27% | 股份 |
| F/m Investments LLC | $10656079 | 187574 | 0.25% | 股份 |
| HSBC HOLDINGS PLC | $10436395 | 183707 | 0.24% | 股份 |
| Caption Management, LLC | $10288291 | 181100 | 0.24% | 买入期权 |
| Hillsdale Investment Management Inc. | $9538399 | 167900 | 0.22% | 股份 |
| Palo Alto Investors LP | $9517095 | 167525 | 0.22% | 股份 |
| Swiss National Bank | $9464546 | 166600 | 0.22% | 股份 |
| MACKENZIE FINANCIAL CORP | $9462899 | 166571 | 0.22% | 股份 |
| ALGERT GLOBAL LLC | $9451593 | 166372 | 0.22% | 股份 |
| SEB Asset Management AB | $9355055 | 164673 | 0.22% | 股份 |
| Aquatic Capital Management LLC | $8959505 | 157710 | 0.21% | 股份 |
| Russell Investments Group, Ltd. | $8774190 | 154448 | 0.20% | 股份 |
| BlackRock, Inc. | $8640347 | 152092 | 0.20% | 股份 |
| Knott David M Jr | $8367090 | 147282 | 0.19% | 股份 |
| Voleon Capital Management LP | $8274661 | 145655 | 0.19% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $8273979 | 145643 | 0.19% | 股份 |
| JANUS HENDERSON GROUP PLC | $7769924 | 261537 | 0.18% | 股份 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $7604927 | 133866 | 0.18% | 股份 |
| MORGAN STANLEY | $7526553 | 132486 | 0.17% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6779194 | 119331 | 0.16% | 股份 |
| Lisanti Capital Growth, LLC | $6760674 | 119005 | 0.16% | 股份 |
| Informed Momentum Co LLC | $6702841 | 117987 | 0.16% | 股份 |
| RHUMBLINE ADVISERS | $6461781 | 113744 | 0.15% | 股份 |
| Apis Capital Advisors, LLC | $6362720 | 112000 | 0.15% | 股份 |
| CITIGROUP INC | $6242567 | 109885 | 0.14% | 股份 |
| Squarepoint Ops LLC | $6238136 | 109807 | 0.14% | 股份 |
| JANE STREET GROUP, LLC | $6044584 | 106400 | 0.14% | 买入期权 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5920056 | 104208 | 0.14% | 股份 |
| CITADEL ADVISORS LLC | $5862792 | 103200 | 0.14% | 买入期权 |
| RICE HALL JAMES & ASSOCIATES, LLC | $5543122 | 97573 | 0.13% | 股份 |
| ExodusPoint Capital Management, LP | $5535680 | 97442 | 0.13% | 股份 |
| Calamos Advisors LLC | $5462395 | 96152 | 0.13% | 股份 |
| SummitTX Capital, L.P. | $5454783 | 96018 | 0.13% | 股份 |
| ALPS ADVISORS INC | $5339061 | 93981 | 0.12% | 股份 |
| CITADEL ADVISORS LLC | $5237882 | 92200 | 0.12% | 卖出期权 |
| 1832 Asset Management L.P. | $5004961 | 88100 | 0.12% | 股份 |
| HighVista Strategies LLC | $4898896 | 86233 | 0.11% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $4812546 | 84713 | 0.11% | 股份 |
| Ishara Investments LP | $4658420 | 82000 | 0.11% | 股份 |
| SECTOR GAMMA AS | $4544800 | 80000 | 0.11% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $4229391 | 74448 | 0.10% | 股份 |
| Quantinno Capital Management LP | $4025727 | 70863 | 0.09% | 股份 |
| XTX Topco Ltd | $3631182 | 63918 | 0.08% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3623738 | 63787 | 0.08% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $3384513 | 59576 | 0.08% | 股份 |
公司内部人士 29 位内幕人士 · 13 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Eric M Dube | Chief Executive Officer | 2023年9月5日 S | 242595 | 0 | 0 | $0 |
| Christopher R. Cline | Chief Financial Officer | 2023年9月5日 S | 50574 | 0 | 0 | $0 |
| Laura Clague | Chief Financial Officer | 2022年5月11日 S | 35655 | 0 | 0 | $0 |
| Marc L Panoff | Chief Financial Officer | 2014年2月24日 A | 221100 | 0 | 0 | $0 |
| Neil F. Mcfarlane | Chief Operating Officer | 2019年5月16日 S | 26988 | 0 | 0 | $0 |
| Jula Inrig | CHIEF MEDICAL OFFICER | 2026年6月22日 G | 112770 | 0 | 0 | $0 |
| Peter Heerma | Chief Commercial Officer | 2023年10月3日 S | 80257 | 0 | 0 | $0 |
| William E. Rote | Senior Vice President, R&D | 2023年9月5日 S | 61173 | 0 | 0 | $0 |
| Sandra Calvin | SVP, Chief Accounting Officer | 2023年5月11日 S | 42247 | 0 | 0 | $0 |
| Noah L. Rosenberg | Chief Medical Officer | 2021年8月17日 S | 47614 | 0 | 0 | $0 |
| Alvin Shih | EVP of Research & Development | 2016年9月1日 S | 158334 | 0 | 0 | $0 |
| VALEUR JENSEN MARGARET E | General Counsel | 2016年2月1日 A | 100000 | 0 | 0 | $0 |
| Horacio Plotkin | Chief Medical Officer | 2014年12月12日 S | 91767 | 0 | 0 | $0 |
| Roy D. Baynes | 董事 | 2026年6月12日 M | 41500 | 0 | 1 | $-225000 |
| Timothy Coughlin | 董事 | 2026年6月12日 M | 56250 | 0 | 3 | $-1272582 |
| LYONS GARY A | 董事 | 2026年5月19日 A | 61500 | 0 | 1 | $-328560 |
| Sandra Poole | 董事 | 2023年5月17日 A | 17000 | 0 | 0 | $0 |
| Suzanne Louise Bruhn | 董事 | 2023年5月17日 A | 15750 | 0 | 0 | $0 |
| Jeffery A. Meckler | 董事 | 2023年5月17日 A | 74500 | 0 | 0 | $0 |
| John A Orwin | 董事 | 2023年5月17日 A | 22375 | 0 | 0 | $0 |
| Ron Squarer | 董事 | 2023年5月17日 A | 22375 | 0 | 0 | $0 |
| Steve Aselage | 董事 | 2022年5月11日 S | 146919 | 0 | 0 | $0 |
| John W Kozarich | 董事 | 2019年5月8日 A | 29000 | 0 | 0 | $0 |
| Steven Gary Richardson | 董事 | 2014年11月21日 P | 129165 | 0 | 0 | $0 |
| Jeffrey Paley | 董事 | 2014年8月14日 S | 51665 | 0 | 0 | $0 |
| Ruth Williams Brinkley | — | 2026年5月19日 A | 29750 | 0 | 0 | $0 |
| Elizabeth E Reed | — | 2026年5月4日 M | 105211 | 0 | 16 | $-4928520 |
| Cornelius E Golding | — | 2016年5月18日 A | 29000 | 0 | 0 | $0 |
| Martin Shkreli | — | 2014年9月12日 J | 1765168 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Opaleye L.P ×3 申报 | 2015年6月5日 | — | 初始申报 | — | SEC |
| MSMB Capital Management LP, MSMB Capital Management LLC, MSMB Healthcare LP, MSMB Healthcare Investors LLC, MSMB Healthcare Management LLC, Martin Shkreli ×2 申报 | 2013年2月19日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 53 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 7.67% | 170714 NS | 2026年5月31日 | N-PORT |
| PJP · Invesco Exchange-Traded Fund Trust | 3.52% | 290649 SH | 2026年8月8日 | 每日 |
| SBIO · ALPS ETF Trust | 2.77% | 95051 NS | 2026年5月31日 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 2.28% | 91638 SH | 2026年8月8日 | 每日 |
| SPIT · RBB Fund, Inc. | 2.06% | 14023 NS | 2026年4月30日 | N-PORT |
| BBP · ETFis Series Trust I | 1.93% | 27170 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 1.33% | 164067 NS | 2026年4月30日 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund ... | 1.06% | 11744 NS | 2026年5月31日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.81% | 37788 SH | 2026年8月8日 | 每日 |
| BRNY · EA Series Trust | 0.64% | 84570 NS | 2026年4月30日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.63% | 157219 NS | 2026年4月30日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.43% | 31899 SH | 2026年8月8日 | 每日 |
| IBB · iShares Trust | 0.43% | 662786 SH | 2026年8月8日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.39% | 5059 SH | 2026年8月8日 | 每日 |
| IWO · iShares Trust | 0.34% | 809244 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.30% | 95695 SH | 2026年8月8日 | 每日 |
| OASC · Unified Series Trust | 0.28% | 4971 NS | 2026年5月31日 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund ... | 0.28% | 5759 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.26% | 54435 NS | 2026年5月31日 | N-PORT |
| ESSC · Strategy Shares | 0.25% | 1513 NS | 2026年4月30日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.24% | 70102 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.22% | 3409 NS | 2026年5月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.19% | 32277 NS | 2026年4月30日 | N-PORT |
| ISCG · iShares Trust | 0.18% | 29119 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.18% | 2265933 SH | 2026年8月8日 | 每日 |
| BKSE · BNY Mellon ETF Trust | 0.17% | 3185 NS | 2026年4月30日 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.15% | 8833 NS | 2026年5月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.15% | 514614 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.15% | 70504 SH | 2026年8月8日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.13% | 14646 NS | 2026年4月30日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.11% | 37027 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.11% | 35731 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.10% | 3881 NS | 2026年5月31日 | N-PORT |
| FBCG · FIDELITY COVINGTON TRUST | 0.09% | 133749 NS | 2026年4月30日 | N-PORT |
| ISCB · iShares Trust | 0.09% | 4157 SH | 2026年8月8日 | 每日 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.09% | 431230 NS | 2026年5月31日 | N-PORT |
| ESML · iShares Trust | 0.09% | 39850 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.07% | 249426 SH | 2026年8月8日 | 每日 |
| SMLF · iShares Trust | 0.07% | 46167 SH | 2026年8月8日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.06% | 1066102 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.06% | 3036 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.06% | 38888 NS | 2026年4月30日 | N-PORT |
| WSML · iShares Trust | 0.05% | 4868 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.04% | 3073 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.02% | 3488 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.02% | 77 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 26832 NS | 2026年5月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 2948502 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 7348 SH | 2026年8月8日 | 每日 |
| ITOT · iShares Trust | 0.01% | 124087 SH | 2026年8月8日 | 每日 |